Co-Founder and CSO
I
InSimili
InSimili offers a platform that recreates physiological and pathological microenvironments within standard cell cultures, enabling more accurate in-vitro drug efficacy testing. This allows pharmaceutical companies to better evaluate drug candidates early in development, reducing the risk of clinical trial failures.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- InSimili offers a platform that recreates physiological and pathological microenvironments within standard cell cultures, enabling more accurate in-vitro drug efficacy testing. This allows pharmaceutical companies to better evaluate drug candidates early in development, reducing the risk of clinical trial failures.